VAERS reports by lot

Merck Pneumococcal lot U032086: VAERS reports

40 VAERS reports list lot U032086 as a Merck Pneumococcal vaccine, received between 2022-09-19 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
40
Reports
2%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4449%
General / Systemic (non-local)1112%
Musculoskeletal910%
Cardiac / Cardiovascular89%
Allergic / Anaphylactic56%
Gastrointestinal56%
Dermatological (non-injection-site)56%
Neurological22%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida5
California5
Illinois4
Texas3
Ohio2
Virginia2
New York2
New Hampshire2
Missouri1
Arizona1
North Carolina1
Washington1

Reports by month received

2022-091
2022-106
2022-113
2022-124
2023-012
2023-022
2023-031
2023-042
2023-061
2023-099
2023-102
2023-111
2023-122
2024-031
2024-063

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.